Skip to main content
Emergency MedicineCondition·Updated Jul 22, 2026·v1

Serum Osmolal Gap

The serum osmolal gap is a bedside screening tool for toxic alcohol poisoning; an elevated gap with high anion gap metabolic acidosis mandates empiric fomepizole and consideration of hemodialysis, but a normal gap does not exclude poisoning.

Low Evidence47 references·9,431 words·38 min read·v1
serum osmolal gaptoxic alcohol poisoningmethanolethylene glycolisopropanolpropylene glycolfomepizolehemodialysisanion gap metabolic acidosis
On this page

Quick Reference

RxDrug of choiceFomepizole 15 mg/kg IV loading, then 10 mg/kg every 12 hours (adjust for hemodialysis)
AltAlternativesEthanol IV (target serum level 100-150 mg/dL) if fomepizole unavailable
AvoidNo specific contraindications to fomepizole; avoid ethanol in patients with liver disease or hypoglycemia risk
DxTest of choiceSerum osmolal gap using simplified formula (2×Na+1.2×Urea+1.4×Glucose+1.2×Ethanol) with confirmatory methanol/ethylene glycol levels
ScKey scoreNot applicable; pH has highest ROC area (0.94) for prognosis in methanol poisoning
When to referTransfer to dialysis-capable facility if hemodialysis not available; consult medical toxicology for complex cases
An elevated OG >10 mOsm/kg with high anion gap metabolic acidosis is highly suspicious for toxic alcohol poisoning; treat empirically with fomepizole and dialysis if severe.
The serum osmolal gap (OG) is the difference between measured and calculated osmolality, a bedside screening tool for toxic alcohol poisoning. An elevated gap (>10 mOsm/kg using the simplified formula 2×Na+1.2×Urea+1.4×Glucose+1.2×Ethanol) raises suspicion for methanol, ethylene glycol, or isopropanol ingestion, but a normal gap does not rule out poisoning, especially in late presenters or with diethylene glycol. The gap must be interpreted alongside the anion gap, pH, and clinical context. Empiric fomepizole (15 mg/kg IV) should be started immediately when suspicion is high, without waiting for confirmatory levels. Hemodialysis is indicated for severe acidosis (pH<7.2), end-organ damage, or high levels. Non-toxic causes (diabetic ketoacidosis, alcoholic ketoacidosis, propylene glycol, multiple myeloma) can also elevate the gap and must be considered.

Overview and Recommendations

Background

  • The serum osmolal gap (OG) is the difference between directly measured serum osmolality (by freezing point depression) and calculated osmolarity using sodium, urea, glucose, and ethanol. It flags the presence of unmeasured osmotically active solutes, most critically toxic alcohols.
  • Two types exist: the serum OG for toxic alcohol screening and the urine osmolal gap (UOG) for evaluating renal tubular acidosis. The serum OG is the focus of this page; the UOG is used to estimate urine ammonium in hyperchloremic metabolic acidosis.
  • Untreated methanol or ethylene glycol poisoning carries mortality > in some series; early recognition and treatment with fomepizole and hemodialysis can be life-saving. The OG is the most accessible surrogate marker when confirmatory levels are not immediately available.
  • Several calculation formulas exist; the simplified equation 2.0×Na + 1.2×Urea + 1.4×Glucose + 1.2×Ethanol (all in mmol/L) is the most accurate, with 95% of normal values between -10.9 and 13.8 mOsm/kg. This formula improves diagnostic accuracy for toxic alcohol exposure compared with older published equations.
  • A critical pitfall: a normal OG does not exclude toxic alcohol poisoning. In a pediatric outbreak of diethylene glycol intoxication, the mean OG was only 3.46 ± 4.68 mOsm/kg yet mortality was 37.5%. The OG must never be used alone to rule out poisoning.

Evaluation

  • Suspect toxic alcohol ingestion in any patient with unexplained high anion gap metabolic acidosis (HAGMA), visual disturbances, altered mental status, or acute kidney injury. Calculate the osmolal gap using the simplified formula as the first bedside step.
  • Ask about the timing of ingestion, co-ingestion of ethanol, specific symptoms (visual blurring with methanol, flank pain with ethylene glycol), history of alcohol abuse (alcoholic ketoacidosis), exposure to medical drugs (propylene glycol from continuous IV lorazepam or pentobarbital), and product details (hand sanitizer, antifreeze, syrup medications in children).
  • Examine for vital signs, mental status, pupillary response (methanol can cause dilated pupils and papilledema), CNS depression, fruity breath odor (isopropanol), and signs of acute kidney injury. Visual symptoms are a red flag for methanol poisoning.
  • Order serum osmolality (freezing point), electrolytes (Na, K, Cl, HCO3), BUN, glucose, ethanol level, arterial blood gas, lactate, and send methanol and ethylene glycol levels. Also order urinalysis for oxalate crystals (ethylene glycol) and ketones (isopropanol, AKA).
  • Diagnostic criteria: an elevated OG ≥10 mOsm/kg with HAGMA is classic for methanol or ethylene glycol. Isopropanol causes elevated OG with ketosis but no metabolic acidosis. Alcoholic ketoacidosis (AKA) presents with elevated OG and HAGMA but resolves with volume repletion and dextrose.
  • Also consider non-toxic causes: diabetic ketoacidosis, alcoholic ketoacidosis, chronic kidney disease, multiple myeloma (paraproteins), pseudohyponatremia (from hyperproteinemia or hyperlipidemia), and propylene glycol toxicity (iatrogenic from IV lorazepam/pentobarbital). The OG can be elevated in these conditions and mimic toxic alcohol poisoning.
  • Red flags: visual symptoms mandate urgent ophthalmology consultation and antidote initiation; acute kidney injury with calcium oxalate crystals requires immediate hemodialysis; profound bradyarrhythmia in a patient on high-dose lorazepam suggests propylene glycol toxicity and may require dialysis.

Management

  • Initiate 15 mg/kg IV loading dose, then 10 mg/kg every 12 hours for 4 doses, then 15 mg/kg every 12 hours if needed (dose per standard protocol; adjust for hemodialysis). Start empirically when toxic alcohol poisoning is suspected, ideally within 1 hour of presentation, without waiting for confirmatory levels.
  • If fomepizole is unavailable, administer IV to achieve a serum ethanol level of 100-150 mg/dL. Ethanol requires frequent monitoring of serum levels and has a narrower therapeutic window; it is less well tolerated than fomepizole.
  • Initiate for severe poisoning: pH <7.2, osmolal gap >50 mOsm/kg, methanol or ethylene glycol levels >50 mg/dL, visual symptoms, acute kidney injury, or refractory acidosis. Target hemodialysis initiation within 4-6 hours of diagnosis. In methanol poisoning, the OG correlates closely with serum methanol during dialysis (y=1.09x+3.82; R²=0.92) and can guide dialysis duration, potentially reducing dialysis time by 34%.
  • Monitor serum OG, anion gap, arterial blood gas, electrolytes, and renal function every 2-4 hours during therapy. The OG should decline as the toxic alcohol is metabolized or removed. If the gap fails to decrease or acidosis worsens, reassess for ongoing absorption, inadequate dialysis, or an alternative diagnosis such as propylene glycol or alcoholic ketoacidosis.
  • Continue fomepizole until toxic alcohol levels are undetectable or below toxic thresholds. For isopropanol poisoning, no specific antidote exists; management is supportive with airway support and hemodialysis reserved for life-threatening cases with CNS depression or circulatory collapse.
  • What NOT to do: Do not delay hemodialysis while awaiting confirmatory toxic alcohol levels if clinical criteria are met. Do not rely solely on the OG to rule out poisoning; a normal gap does not exclude it, especially in late presenters. Do not administer fomepizole without considering non-toxic causes, while empiric use is justified when suspicion is high, 40% of fomepizole administrations are for non-toxic exposures, incurring significant cost.
  • When to refer: Transfer to a dialysis-capable facility if not available on-site. Consult medical toxicology or nephrology early. For intentional ingestions, obtain psychiatric evaluation before discharge. Discharge criteria: resolution of metabolic acidosis (serum bicarbonate ≥20 mmol/L, normal anion gap), normalization of OG (<10 mOsm/kg), no neurologic or visual symptoms, and psychiatric clearance. For low suspicion cases with normal gaps, observe 6-12 hours with serial labs before discharge.

Board Review — High Yield

  • Osmolal gap formula: 2×Na + 1.2×Urea + 1.4×Glucose + 1.2×Ethanol (all in mmol/L), most accurate; normal range -10.9 to 13.8 mOsm/kg
  • Normal gap does not rule out: In diethylene glycol outbreak, mean OG was 3.46 mOsm/kg despite 37.5% mortality
  • Methanol vs ethylene glycol: Both cause high AG acidosis + elevated OG, but methanol causes visual disturbances; ethylene glycol causes oxalate crystalluria and AKI
  • Isopropanol: Elevated OG + ketonemia without acidosis; no antidote, supportive care
  • Propylene glycol: Double gap (high AG + high OG) from high-dose IV lorazepam; treat by stopping drug, consider hemodialysis for severe bradyarrhythmia
  • Alcoholic ketoacidosis: Mimics toxic alcohol poisoning; resolves with fluids and dextrose
  • Pseudohyponatremia: Falsely low Na from hyperproteinemia/hyperlipidemia elevates calculated OG; check direct ISE
  • Fomepizole dose: 15 mg/kg IV loading, then 10 mg/kg q12h; adjust for hemodialysis
  • Hemodialysis indication: pH <7.2, OG >50, methanol/EG >50 mg/dL, end-organ damage
  • OG guides dialysis duration: In methanol, OG correlates with methanol level during dialysis (R²=0.92), can reduce dialysis time by 34%

Deep Dive — Evidence Details

References

  1. [1]

    Lepeytre F, Ghannoum M, Ammann H et al.. Formulas for Calculated Osmolarity and Osmolal Gap: A Study of Diagnostic Accuracy. American journal of kidney diseases : the official journal of the National Kidney Foundation (2017). PMID: 28578820

    L3RETROSPECTIVE_COHORTCited in: Definition, Classification and Nomenclature, Clinical Presentation, The Diagnostic Sieve: Worst-First Differential, Rule-Out Rules & Rapid Workup, Severity, Risk Stratification and Triage, Acute Resuscitation and Stabilization, Resuscitative Procedures, Airway Management & Procedural Sedation, Definitive ED Therapy, Time-to-Intervention Targets & Handoff, Disposition and Safe Discharge, Prognosis and Natural History, Prevention, Screening and ED-Based Interventions
  2. [2]

    Brunner R, Drolz A, Scherzer TM et al.. Renal tubular acidosis is highly prevalent in critically ill patients. Critical care (London, England) (2015). PMID: 25888397

    L3COHORTCited in: Definition, Classification and Nomenclature, Epidemiology, Etiology and Risk Factors, Severity, Risk Stratification and Triage, Acute Resuscitation and Stabilization, Resuscitative Procedures, Airway Management & Procedural Sedation, Definitive ED Therapy, Time-to-Intervention Targets & Handoff, Disposition and Safe Discharge, Complications and Pitfalls, Prognosis and Natural History, Special Populations and Pregnancy, Prevention, Screening and ED-Based Interventions
  3. [3]

    Greenberg KI, Lecker SH. Metabolic Acidosis. Advances in kidney disease and health (2025). PMID: 40175031

    L5NARRATIVE_REVIEWCited in: Definition, Classification and Nomenclature, Mechanisms of the Dangerous Differential, Epidemiology, Etiology and Risk Factors, Clinical Presentation, Severity, Risk Stratification and Triage, Acute Resuscitation and Stabilization, Resuscitative Procedures, Airway Management & Procedural Sedation, Definitive ED Therapy, Time-to-Intervention Targets & Handoff, Disposition and Safe Discharge, Prognosis and Natural History, Prevention, Screening and ED-Based Interventions
  4. [4]

    Büyükkaragöz B, Bakkaloğlu SA. Serum osmolality and hyperosmolar states. Pediatric nephrology (Berlin, Germany) (2022). PMID: 35779183

    L5NARRATIVE_REVIEWCited in: Definition, Classification and Nomenclature, Mechanisms of the Dangerous Differential, Severity, Risk Stratification and Triage, Acute Resuscitation and Stabilization, Resuscitative Procedures, Airway Management & Procedural Sedation, Definitive ED Therapy, Time-to-Intervention Targets & Handoff, Disposition and Safe Discharge, Prognosis and Natural History, Prevention, Screening and ED-Based Interventions
  5. [5]

    Mullins ME, Kraut JA. The Role of the Nephrologist in Management of Poisoning and Intoxication: Core Curriculum 2022. American journal of kidney diseases : the official journal of the National Kidney Foundation (2021). PMID: 34895948

    L5NARRATIVE_REVIEWCited in: Definition, Classification and Nomenclature, Mechanisms of the Dangerous Differential, Epidemiology, Etiology and Risk Factors, Clinical Presentation, Severity, Risk Stratification and Triage, Acute Resuscitation and Stabilization, Resuscitative Procedures, Airway Management & Procedural Sedation, Definitive ED Therapy, Time-to-Intervention Targets & Handoff, Disposition and Safe Discharge, Prognosis and Natural History, Prevention, Screening and ED-Based Interventions
  6. [6]

    Berend K, Duits AJ. The role of the clinical laboratory in diagnosing acid-base disorders. Critical reviews in clinical laboratory sciences (2019). PMID: 30917291

    L5NARRATIVE_REVIEWCited in: Definition, Classification and Nomenclature, Mechanisms of the Dangerous Differential, Clinical Presentation, Severity, Risk Stratification and Triage, Acute Resuscitation and Stabilization, Resuscitative Procedures, Airway Management & Procedural Sedation, Definitive ED Therapy, Time-to-Intervention Targets & Handoff, Disposition and Safe Discharge, Prognosis and Natural History, Special Populations and Pregnancy, Prevention, Screening and ED-Based Interventions
  7. [7]

    Berend K. Review of the Diagnostic Evaluation of Normal Anion Gap Metabolic Acidosis. Kidney diseases (Basel, Switzerland) (2017). PMID: 29344509

    L5NARRATIVE_REVIEWCited in: Definition, Classification and Nomenclature, Severity, Risk Stratification and Triage, Acute Resuscitation and Stabilization, Resuscitative Procedures, Airway Management & Procedural Sedation, Definitive ED Therapy, Time-to-Intervention Targets & Handoff, Disposition and Safe Discharge, Prognosis and Natural History, Prevention, Screening and ED-Based Interventions
  8. [8]

    Kraut JA. Diagnosis of toxic alcohols: limitations of present methods. Clinical toxicology (Philadelphia, Pa.) (2015). PMID: 26114345

    L5NARRATIVE_REVIEWCited in: Definition, Classification and Nomenclature, Severity, Risk Stratification and Triage, Acute Resuscitation and Stabilization, Resuscitative Procedures, Airway Management & Procedural Sedation, Definitive ED Therapy, Time-to-Intervention Targets & Handoff, History and Evolution of Treatment, Disposition and Safe Discharge, Prognosis and Natural History, Prevention, Screening and ED-Based Interventions
  9. [9]

    Slaughter RJ, Mason RW, Beasley DM et al.. Isopropanol poisoning. Clinical toxicology (Philadelphia, Pa.) (2014). PMID: 24815348

    L5NARRATIVE_REVIEWCited in: Definition, Classification and Nomenclature, Mechanisms of the Dangerous Differential, Clinical Presentation, Severity, Risk Stratification and Triage, Acute Resuscitation and Stabilization, Resuscitative Procedures, Airway Management & Procedural Sedation, Definitive ED Therapy, Time-to-Intervention Targets & Handoff, History and Evolution of Treatment, Disposition and Safe Discharge, Prognosis and Natural History, Prevention, Screening and ED-Based Interventions
  10. [10]

    Hidayati EL, Fahlevi R, Puspitasari HA et al.. Emerging progressive atypical acute kidney injury in young children linked to ethylene glycol and diethylene glycol intoxication. Pediatric nephrology (Berlin, Germany) (2023). PMID: 37755463

    L4CROSS_SECTIONALCited in: Definition, Classification and Nomenclature, Epidemiology, Etiology and Risk Factors, Clinical Presentation, Severity, Risk Stratification and Triage, Acute Resuscitation and Stabilization, Resuscitative Procedures, Airway Management & Procedural Sedation, Definitive ED Therapy, Time-to-Intervention Targets & Handoff, History and Evolution of Treatment, Disposition and Safe Discharge, Prognosis and Natural History, Prevention, Screening and ED-Based Interventions
  11. [11]

    Fenves AZ, Emmett M. Approach to Patients With High Anion Gap Metabolic Acidosis: Core Curriculum 2021. American journal of kidney diseases : the official journal of the National Kidney Foundation (2021). PMID: 34400023

    L4CASE_SERIESCited in: Definition, Classification and Nomenclature, Clinical Presentation, Severity, Risk Stratification and Triage, Acute Resuscitation and Stabilization, Resuscitative Procedures, Airway Management & Procedural Sedation, Definitive ED Therapy, Time-to-Intervention Targets & Handoff, Disposition and Safe Discharge, Prognosis and Natural History, Special Populations and Pregnancy, Prevention, Screening and ED-Based Interventions
  12. [12]

    Holzman SD, Larsen J, Kaur R et al.. Death by hand sanitizer: syndemic methanol poisoning in the age of COVID-19. Clinical toxicology (Philadelphia, Pa.) (2021). PMID: 33755514

    L4CASE_SERIESCited in: Definition, Classification and Nomenclature, Severity, Risk Stratification and Triage, Acute Resuscitation and Stabilization, Resuscitative Procedures, Airway Management & Procedural Sedation, Definitive ED Therapy, Time-to-Intervention Targets & Handoff, Disposition and Safe Discharge, Prognosis and Natural History, Prevention, Screening and ED-Based Interventions
  13. [13]

    Rastegar M, Nagami GT. Non-Anion Gap Metabolic Acidosis: A Clinical Approach to Evaluation. American journal of kidney diseases : the official journal of the National Kidney Foundation (2016). PMID: 28029394

    L4CASE_SERIESCited in: Definition, Classification and Nomenclature, Clinical Presentation, Severity, Risk Stratification and Triage, Acute Resuscitation and Stabilization, Resuscitative Procedures, Airway Management & Procedural Sedation, Definitive ED Therapy, Time-to-Intervention Targets & Handoff, History and Evolution of Treatment, Disposition and Safe Discharge, Prognosis and Natural History, Special Populations and Pregnancy, Prevention, Screening and ED-Based Interventions
  14. [14]

    Kraut JA. Approach to the Treatment of Methanol Intoxication. American journal of kidney diseases : the official journal of the National Kidney Foundation (2016). PMID: 27180631

    L4CASE_SERIESCited in: Definition, Classification and Nomenclature, Clinical Presentation, Severity, Risk Stratification and Triage, Acute Resuscitation and Stabilization, Resuscitative Procedures, Airway Management & Procedural Sedation, Definitive ED Therapy, Time-to-Intervention Targets & Handoff, History and Evolution of Treatment, Disposition and Safe Discharge, Prognosis and Natural History, Prevention, Screening and ED-Based Interventions
  15. [15]

    Hsiao PJ, Chen TY, Chiu CC et al.. Delayed high anion gap metabolic acidosis after a suicide attempt: case report. Clinica chimica acta; international journal of clinical chemistry (2014). PMID: 24992526

    L4CASE_SERIESCited in: Definition, Classification and Nomenclature, Severity, Risk Stratification and Triage, Acute Resuscitation and Stabilization, Resuscitative Procedures, Airway Management & Procedural Sedation, Definitive ED Therapy, Time-to-Intervention Targets & Handoff, Disposition and Safe Discharge, Prognosis and Natural History, Special Populations and Pregnancy, Prevention, Screening and ED-Based Interventions
  16. [16]

    Rasouli M. Basic concepts and practical equations on osmolality: Biochemical approach. Clinical biochemistry (2016). PMID: 27343561

    L5NARRATIVE_REVIEWCited in: Definition, Classification and Nomenclature
  17. [17]

    Leonard JB, Minhaj FS, Erickson K et al.. Fomepizole use reported to United States Poison Centers from 2010 to 2021. Clinical toxicology (Philadelphia, Pa.) (2024). PMID: 38465690

    L5OTHERCited in: Definition, Classification and Nomenclature, Clinical Presentation, Severity, Risk Stratification and Triage, Acute Resuscitation and Stabilization, Resuscitative Procedures, Airway Management & Procedural Sedation, Definitive ED Therapy, Time-to-Intervention Targets & Handoff, Disposition and Safe Discharge, Prognosis and Natural History, Prevention, Screening and ED-Based Interventions
  18. [18]

    Fujimaru T, Shuo T, Nagahama M et al.. Assessing urine ammonium concentration by urine osmolal gap in chronic kidney disease. Nephrology (Carlton, Vic.) (2021). PMID: 34288275

    L5OTHERCited in: Definition, Classification and Nomenclature, Mechanisms of the Dangerous Differential, Clinical Presentation, The Diagnostic Sieve: Worst-First Differential, Rule-Out Rules & Rapid Workup, Severity, Risk Stratification and Triage, Acute Resuscitation and Stabilization, Resuscitative Procedures, Airway Management & Procedural Sedation, Definitive ED Therapy, Time-to-Intervention Targets & Handoff, Disposition and Safe Discharge, Prognosis and Natural History, Special Populations and Pregnancy, Prevention, Screening and ED-Based Interventions
  19. [19]

    Ebonwu EO, Nagel SE, Repsold L et al.. Critical evaluation of equations for serum osmolality: Proposals for effective clinical utility. Clinica chimica acta; international journal of clinical chemistry (2020). PMID: 32622969

    L5OTHERCited in: Definition, Classification and Nomenclature, Severity, Risk Stratification and Triage, Acute Resuscitation and Stabilization, Resuscitative Procedures, Airway Management & Procedural Sedation, Definitive ED Therapy, Time-to-Intervention Targets & Handoff, Disposition and Safe Discharge, Prognosis and Natural History, Prevention, Screening and ED-Based Interventions
  20. [20]

    Nguyen MK, Song L, Kao L et al.. Is the Osmolal Concentration of Ethanol Greater Than Its Molar Concentration? Frontiers in medicine (2020). PMID: 31970159

    L5OTHERCited in: Definition, Classification and Nomenclature, Severity, Risk Stratification and Triage, Acute Resuscitation and Stabilization, Resuscitative Procedures, Airway Management & Procedural Sedation, Definitive ED Therapy, Time-to-Intervention Targets & Handoff, Disposition and Safe Discharge, Prognosis and Natural History, Prevention, Screening and ED-Based Interventions
  21. [21]

    Latus J, Kimmel M, Alscher MD et al.. Ethylene glycol poisoning: a rare but life-threatening cause of metabolic acidosis-a single-centre experience. Clinical kidney journal (2012). PMID: 25503773

    L4COHORTCited in: Mechanisms of the Dangerous Differential
  22. [22]

    Kraut JA, Kurtz I. Toxic alcohol ingestions: clinical features, diagnosis, and management. Clinical journal of the American Society of Nephrology : CJASN (2007). PMID: 18045860

    L5NARRATIVE_REVIEWCited in: Mechanisms of the Dangerous Differential, Clinical Presentation
  23. [23]

    Tsao YT, Tsai WC, Yang SP. A life-threatening double gap metabolic acidosis. The American journal of emergency medicine (2008). PMID: 18358977

    L4CASE_SERIESCited in: Mechanisms of the Dangerous Differential, Clinical Presentation, Complications and Pitfalls
  24. [24]

    Shull PD, Rapoport J. Life-threatening reversible acidosis caused by alcohol abuse. Nature reviews. Nephrology (2010). PMID: 20644581

    L4CASE_SERIESCited in: Mechanisms of the Dangerous Differential, History and Evolution of Treatment, Complications and Pitfalls
  25. [25]

    Garibaldi BT, Cameron SJ, Choi M. Pseudohyponatremia in a patient with HIV and hepatitis C coinfection. Journal of general internal medicine (2007). PMID: 17994269

    L4CASE_SERIESCited in: Mechanisms of the Dangerous Differential, Complications and Pitfalls
  26. [26]

    Kamel KS, Halperin ML. An improved approach to the patient with metabolic acidosis: a need for four amendments. Journal of nephrology (2006). PMID: 16736445

    L5NARRATIVE_REVIEWCited in: Mechanisms of the Dangerous Differential
  27. [27]

    Miller MA, Forni A, Yogaratnam D. Propylene glycol-induced lactic acidosis in a patient receiving continuous infusion pentobarbital. The Annals of pharmacotherapy (2008). PMID: 18698010

    L4CASE_SERIESCited in: Mechanisms of the Dangerous Differential, History and Evolution of Treatment, Complications and Pitfalls
  28. [28]

    Santoso DN, Sinuraya FAG, Ambarsari CG. Distal renal tubular acidosis presenting with an acute hypokalemic paralysis in an older child with severe vesicoureteral reflux and syringomyelia: a case report. BMC nephrology (2022). PMID: 35836135

    L4CASE_SERIESCited in: Epidemiology, Etiology and Risk Factors, Complications and Pitfalls
  29. [29]

    Krahn J, Khajuria A. Osmolality gaps: diagnostic accuracy and long-term variability. Clinical chemistry (2006). PMID: 16455871

    L3COHORTCited in: Clinical Presentation, The Diagnostic Sieve: Worst-First Differential, Rule-Out Rules & Rapid Workup
  30. [30]

    Kraut JA, Xing SX. Approach to the evaluation of a patient with an increased serum osmolal gap and high-anion-gap metabolic acidosis. American journal of kidney diseases : the official journal of the National Kidney Foundation (2011). PMID: 21794966

    L4CASE_SERIESCited in: Clinical Presentation
  31. [31]

    Hovda KE, Julsrud J, Øvrebø S et al.. Studies on ethylene glycol poisoning: one patient - 154 admissions. Clinical toxicology (Philadelphia, Pa.) (2011). PMID: 21824058

    L4CASE_SERIESCited in: Clinical Presentation, Complications and Pitfalls
  32. [32]

    Wallace EA, Green AS. Methanol toxicity secondary to inhalant abuse in adult men. Clinical toxicology (Philadelphia, Pa.) (2009). PMID: 19012086

    L5OTHERCited in: Clinical Presentation, History and Evolution of Treatment
  33. [33]

    Kapur G, Valentini RP, Imam AA et al.. Serum osmolal gap in patients with idiopathic nephrotic syndrome and severe edema. Pediatrics (2007). PMID: 17485452

    L5OTHERCited in: Clinical Presentation, Complications and Pitfalls
  34. [34]

    Sadilek M, Feldman K, Murray KF et al.. Detection of polyethylene glycol-based laxatives in stool. Journal of pediatric gastroenterology and nutrition (2010). PMID: 20118809

    L5OTHERCited in: Clinical Presentation
  35. [35]

    Malkan R, Baillio M, Gao HT et al.. Elevated Osmolal Gap in a Case of Multiple Myeloma. The Journal of emergency medicine (2023). PMID: 38403563

    L4CASE_SERIESCited in: Clinical Presentation, History and Evolution of Treatment, Complications and Pitfalls
  36. [36]

    Coulter CV, Farquhar SE, McSherry CM et al.. Methanol and ethylene glycol acute poisonings - predictors of mortality. Clinical toxicology (Philadelphia, Pa.) (2011). PMID: 22091788

    L5NARRATIVE_REVIEWCited in: The Diagnostic Sieve: Worst-First Differential, Rule-Out Rules & Rapid Workup
  37. [37]

    Hunderi OH, Hovda KE, Jacobsen D. Use of the osmolal gap to guide the start and duration of dialysis in methanol poisoning. Scandinavian journal of urology and nephrology (2006). PMID: 16452060

    L5OTHERCited in: The Diagnostic Sieve: Worst-First Differential, Rule-Out Rules & Rapid Workup
  38. [38]

    Cao D, Maynard S, Mitchell AM et al.. Point of care testing provides an accurate measurement of creatinine, anion gap, and osmolal gap in ex-vivo whole blood samples with nitromethane. Clinical toxicology (Philadelphia, Pa.) (2014). PMID: 24844579

    L5OTHERCited in: Severity, Risk Stratification and Triage, Acute Resuscitation and Stabilization, Resuscitative Procedures, Airway Management & Procedural Sedation, Definitive ED Therapy, Time-to-Intervention Targets & Handoff, Disposition and Safe Discharge, Prognosis and Natural History, Prevention, Screening and ED-Based Interventions
  39. [39]

    Cadnapaphornchai P, Taher S, Bhathena D et al.. Ethylene glycol poisoning: diagnosis based on high osmolal and anion gaps and crystalluria. Annals of emergency medicine (1981). PMID: 7224256

    L4CASE_SERIESCited in: History and Evolution of Treatment
  40. [40]

    Posthuma N, ter Wee PM, Donker AJ et al.. Serum disaccharides and osmolality in CCPD patients using icodextrin or glucose as daytime dwell. Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis (1997). PMID: 9655161

    L1RCTCited in: History and Evolution of Treatment
  41. [41]

    Cawley MJ. Short-term lorazepam infusion and concern for propylene glycol toxicity: case report and review. Pharmacotherapy (2001). PMID: 11560204

    L4CASE_SERIESCited in: History and Evolution of Treatment
  42. [42]

    Höjer J. Severe metabolic acidosis in the alcoholic: differential diagnosis and management. Human & experimental toxicology (1996). PMID: 8793530

    L5NARRATIVE_REVIEWCited in: History and Evolution of Treatment
  43. [43]

    Prevost M, Sun Y, Servilla KS et al.. Repeated intoxication presenting with azotemia, elevated serum osmolal gap, and metabolic acidosis with high anion gap: differential diagnosis, management, and prognosis. International urology and nephrology (2010). PMID: 20602169

    L4CASE_SERIESCited in: History and Evolution of Treatment, Complications and Pitfalls, Special Populations and Pregnancy
  44. [44]

    Lolin Y, Francis DA, Flanagan RJ et al.. Cerebral depression due to propylene glycol in a patient with chronic epilepsy--the value of the plasma osmolal gap in diagnosis. Postgraduate medical journal (1988). PMID: 3249707

    L4CASE_SERIESCited in: History and Evolution of Treatment
  45. [45]

    Lim AK, Choi MJ. Distal renal tubular acidosis associated with Sjogren syndrome. Internal medicine journal (2013). PMID: 24330363

    L4CASE_SERIESCited in: Complications and Pitfalls, Special Populations and Pregnancy
  46. [46]

    Ahmed A, Tschetter PA, Krasowski MD et al.. Massive ethylene glycol poisoning triggers osmotic demyelination syndrome. The Journal of emergency medicine (2013). PMID: 24199725

    L4CASE_SERIESCited in: Complications and Pitfalls
  47. [47]

    Fazekas AS, Funk GC, Klobassa DS et al.. Evaluation of 36 formulas for calculating plasma osmolality. Intensive care medicine (2012). PMID: 23081685

    L5OTHERCited in: Special Populations and Pregnancy

Revision History

All updates applied to this page

Loading revisions…